ArticleBBA advances2026
MRPL12 regulates high glucose-induced ferroptosis in renal tubular epithelial cells via GPX4.
Article in BBA advances, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Diabetic kidney disease (DKD) is a severe chronic complication of diabetes and one of the major causes of end-stage renal disease (ESRD). Increasing evidence implicates ferroptosis in pathological cell death associated with metabolic diseases, carcinogenesis, and ischemia-reperfusion injury, which is also thought to be involved in kidney tubular cell death under diabetic conditions; however, the underlying pathogenic mechanism remains unclear. We found increased iron level and cellular lipid peroxidation in streptozotocin (STZ)-induced DKD mice and high glucose-stimulated renal tubular cells, accompanied by mitochondrial morphological and functional damages. Further research showed that the expression of mitochondrial ribosomal protein L12 (MRPL12) was downregulated in high glucose conditions. Overexpression of MRPL12 alleviated the damages caused by high glucose-induced ferroptosis in renal tubular cells. MRPL12 interacts with murine double minute 2 (MDM2), an E3 ubiquitin-protein ligase involved in the ubiquitination degradation pathway of several proteins. MRPL12 plays a crucial regulatory role in high glucose-induced ferroptosis of renal tubular epithelial cells by modulating glutathione peroxidase 4 (GPX4), which is a potential novel therapeutic target in improving mitochondrial homeostasis and promoting renal function.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.